Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Altria Group (NY:MO)

67.58 +1.02 (+1.53%)
Official Closing Price Updated: 4:10 PM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Altria Group

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
58 59 Next >
3 Sorry Dividend Stocks to Sell in August Before It’s Too Late
Even high-yield dividend stocks aren't the safe haven some investors see them as, and these three have fundamental weaknesses. 
Via InvestorPlace
As Cannabis Consumption Surges While Alcohol Falls, This Expert Sees A $100B Market Opportunity For Weed
"Since 2010, cannabis use among ages 21-29 is up 55%, while alcohol use is down 11%. 
Via Benzinga
Topics Cannabis
3 Stocks to Buy at a Massive Discount Right Now
These sale prices won't last forever. Act now while you still can. 
Via The Motley Fool
My Top Dividend King to Buy and Hold for the Next 10 Years, and It Isn't Even Close
This stock offers a high dividend yield, impressive dividend growth, and a lot more. 
Via The Motley Fool
Could Altria's Dividend Continue to Grow?
Management just updated its long-term strategy for its dividend payouts. But should investors have faith in it? 
Via The Motley Fool
The 3 Most Reliable Dividend Stocks to Buy for August 2023
As equities remain volatile this month, fixed-income investments are gaining attention. Here are three of the most reliable dividend stocks. 
Via InvestorPlace
(MO) - Analyzing Altria Group's Short Interest
 
Via Benzinga
Altria Stock: Buy, Sell, or Hold?
The tobacco company has held up surprisingly well against industrywide headwinds, but there's still no compelling end to its story. 
Via The Motley Fool
Altria Group (MO) Q2 2023 Earnings Call Transcript
MO earnings call for the period ending June 30, 2023. 
Via The Motley Fool
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Results from Human Oral Nicotine Study Evaluating DehydraTECH(TM)-Nicotine
Via CannabisNewsWire
Topics Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Results from Human Oral Nicotine Study Evaluating DehydraTECH(TM)-Nicotine
Via Investor Brand Network
Topics Intellectual Property
5 Best Dividend Stocks to Buy in August 2023
The markets are always looking forward, and you should, too. Here are five dividend stocks to buy now. 
Via The Motley Fool
Dividend Income Update July 2023
The start of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. 
Via Talk Markets
Earnings Outlook For Altria Group
 
Via Benzinga
Is Altria Group's 8.2% Dividend Yield Safe for the Long Run?
The tobacco company is struggling to divest away from the declining industry. 
Via The Motley Fool
Better Buy: Altria vs. Procter & Gamble
Considering Altria for its big yield? You might want to think about the longevity of its cash cow business. P&G could be a better choice. 
Via The Motley Fool
Growth Stocks Vs. Dividend Growth Stocks: Which Is Better For You?
A look at the differences between investing in growth stocks vs. dividend growth stocks and how the concept of valuation plays a role in both types of investments. 
Via Talk Markets
3 Price Increases in 7 Months: Should Altria Shareholders Be Worried?
Altria's business model is simple: Milk a cash cow business to pay dividends. But there's a problem investors need to watch. 
Via The Motley Fool
Do Your Investments Pass the 5.45% Test? Here's How To Avoid Leaving Money On The Table
Imagine you're in a candy shop, and you have just enough money for one sweet treat. The problem? You're torn between a chocolate bar and a bag of gummy bears. That's when the principle of opportunity... 
Via Benzinga
Altria Group Q2: Inline EPS, Reaffirmed FY23 Earnings Guidance & More
Altria Group Inc (NYSE: MO) reported second-quarter FY23 Revenues net of excise taxes growth of 1.2% to $5.438 billion, marginally missing the 
Via Benzinga
Altria Reports 2023 Second-Quarter and First-Half Results; Reaffirms 2023 Full-Year Earnings Guidance
From Altria Group, Inc.
Via Business Wire
Want $500 in Super Safe Annual Dividend Income? Invest $9,900 in the Following 3 Dividend Kings
These truly rock-solid income stocks, which sport an average yield of 5.07%, can pad patient investors' wallets. 
Via The Motley Fool
Altria Group Queues For Q2 Earnings: What's In The Cards?
Altria Group, Inc. is likely to register top-and-bottom-line growth when it reports second-quarter 2023 earnings on Aug 1. 
Via Talk Markets
July Summary: Upward Trend In Conservative "Cannabis" Stocks Continues
The Conservative 
Via Talk Markets
The Best Dividend Stocks to Invest $1,000 in Right Now
Investing in these three dividend stocks can provide reliable income for years to come. 
Via The Motley Fool
Where Will Altria Be in 5 Years?
If the past five years is any indication, the next five could be an important turning point for Altria's key tobacco business. 
Via The Motley Fool
Should You Buy the 5 Highest-Paying Dividend Stocks in the S&P 500?
Big yields don't mean much if the dividend can't be grown, or even sustained. 
Via The Motley Fool
EXCLUSIVE: Key Insights And 4 Predictions On Cannabis Sector Equity Research For 2024
In an exclusive preview from Zuanic & Associates' recent cannabis equity research report, Benzinga reveals four key predictions for the next 18 months. 
Via Benzinga
Altria: Buy, Sell, or Hold?
Altria's cigarette business continues to throw off lots of cash to support the stock's huge 8.2% dividend yield. It may not last. 
Via The Motley Fool
4 Best Stocks to Buy Now Under $100
The markets are always looking forward, and you should, too. 
Via The Motley Fool
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
58 59 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.